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The LTRs of HIV-1 and HTLV-I have been shown by several laboratories to be activated by 12-O-tetradecanoylphorbol-
13-acetate (TPA). This agent is a potent activator of protein kinase C (PKC). However, long exposure to TPA downregulates
PKC in many cell types. We demonstrated that TPA treatment of Jurkat cells for more than 24 hr resulted in a sever depletion
of this enzyme. Therefore, to explore the role of PKC in the effect of TPA on these LTRs, we transfected Jurkat cells with
HIV-1 LTR-CAT or HTLV-I LTR-CAT construct after 72 hr of TPA pretreatment. While this TPA pretreatment considerably
reduced the HIV-1 LTR basal expression, it strongly stimulated the expression of HTLV-I LTR. Furthermore, when TPA was
added after transfection, a strong stimulation of HIV-1 LTR was observed, which could be abrogated by PKC inhibitors like
H7 and chelerythryn. However, under these conditions TPA stimulated HTLV-I LTR to a lesser extent than did the long-
term TPA pretreatment. Moreover, this stimulation was enhanced by the PKC inhibitors. Thus our data indicate that while
the effect of TPA on HIV-1 LTR is strictly dependent on PKC activity, its effect on HTLV-I LTR is exerted via a different
pathway that not only does not require PKC activation but rather seems to be antagonized by the activated PKC. Using a
deletion mutant of HTLV-I LTR we mapped the PKC-independent effect of TPA to the c-ets responsive region 1 (ERR-1)
located in U3 of this LTR. q 1997 Academic Press
INTRODUCTION and Curran, 1996; Luciw, 1996). It should also be indi-
cated that the HTLV-I transactivator tax gene product
Human immunodeficiency virus type-1 (HIV-1) and
can activate a variety of cellular genes, some of whichhuman T-cell leukemia virus type-I (HTLV-I) are patho-
play a central role in cell growth control (Aboud et al.,genic retroviruses with complex regulatory systems
1993). Therefore tax is widely regarded as responsiblecontrolling their gene expression. HIV-I is etiologically
for, at least, the initial steps of the multistage leukemo-associated with acquired immunodeficieny syndrome
genic process associated with this virus. Thus, al-(AIDS) (Hirsch and Curran, 1996; Luciw, 1996),
though no (Aboud et al., 1993; Cann and Chen, 1996)whereas HTLV-I is implicated with adult T-cell leuke-
or minimal (Furukawa et al., 1995; Kinoshita et al.,mia (ATL) (Aboud et al., 1993; Cann and Chen, 1996)
1989) virus expression is apparent during the variousand tropical spastic paraparesis/HTLV-I associated
clinical stages of ATL, a temporary high virus expres-myelopathy (TSP/HAM) (Greenberg, 1995). In vitro in-
sion is plausibly needed for providing a sufficientlyfection of human T-cells with these viruses usually re-
high level of tax protein required for initiating this leu-sults in their active gene expression. By contrast, after
kemogenic process. Therefore, in order to exert theirin vivo infection both viruses enter into a latent state,
pathogenicity, both viruses must conceivably be acti-rendering the infected individuals seropositive asymp-
vated from their latent state.tomatic carriers with no (Aboud et al., 1993; Cann and
We have recently demonstrated that a DNA damagingChen, 1996; Luciw, 1996) or very low level (Furukawa
agent, like the carcinogen 3-methylcholanthrene, stimu-et al., 1995; Kinoshita et al., 1989; Luciw, 1996) of viral
lates HTLV-I expression and activates a reporter genegene expression in their infected cells. However, the
expression directed by HTLV-I LTR (Revazovza et al.,clinical courses of AIDS and TSP/HAM are character-
1995). Other laboratories have shown that DNA damag-ized by high expression of the causative virus, which
ing agents can activate HIV-1 gene expression as wellappears to account for most of their immunological and
(Stein et al., 1989a,b; Valerie, 1988; Wallace and Lusker,pathological manifestations (Greenberg, 1995; Hirsch
1992). These data suggest that environmental or nutri-
tional DNA damaging agents, such as chemical carcino-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 011-972-7-6277453. E-mail: aboud@bgumail.bgu.ac.il. gens and radiation, may trigger this activation.
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Another important group of exogenous factors that
have been shown to activate both HIV-1 (Dinter et al.,
1987; Kaufman et al., 1987; Sekevitz et al., 1987; Tong
Starsken et al., 1989) and HTLV-I (Aboud et al., 1993;
Wolfson et al., 1994) includes the phorbol and diterpen
esters, which are plant products (Matsuda et al., 1984;
Nakao et al., 1984; Touraine et al., 1977), potentially ac-
cessible to human contact or consumption. The most
intensively investigated member of this group, 12-O-tetra-
decanoylphorbol-13-acetate (TPA), is a potent activator
of protein kinase C (PKC) and most of its biological ef-
fects are considered to be induced through signaling
pathways involving this enzyme (Jaken, 1990). Notably,
FIG. 1. Schematic presentation of HTLV-I LTR and its ERR1-deletedhowever, long exposure to this agent downregulates PKC
mutant. The structure of the wild-type HTLV-I LTR is shown in (A). Thein many cell types and leads to its depletion (Jaken, 1990). numbers indicate the nucleotide positions relative to the transcription
It is important, therefore, to emphasize that in all previous starting point designated as zero point. The horizontal thin and thick
studies demonstrating TPA-induced activation of these lines represent the sense and antisense strands, respectively. The
black boxes represent the 21-bp tax responsive elements, whereas theviral LTRs, TPA was added after transfection, namely
hatched box represents the 44-bp ERR1 (from 0160 to 0117). ThePKC activation occurred when the examined LTR was
broken horizontal lines at the 5*-side of the LTR represent the immedi-already present within the cells (Aboud et al., 1993; Kauf- ate upstream sequences of the plasmid vector, carrying the XhoI site
man et al., 1987; Sekevitz et al., 1987; Tong-Starksen et used for cloning the ERR1-lacking XhoI–EcoNI fragment shown in (B),
al., 1989). Tong-Starksen et al. (1989) have shown that that was generated as detailed under Materials and Methods.
under such conditions the effect of TPA on HIV-1 LTR can
be blocked by PKC inhibitors, thus providing a persuasive ERR1 [designated HTLV-I LTR(dERR1)-CAT] as follows:
evidence that this effect is mediated by the activated Using the wild-type LTR as template (see Fig. 1A), a
PKC. However, the role of this enzyme in the stimulatory fragment extending from the XhoI site upstream to the
effect of TPA on HTLV-I LTR has not been similarly estab- LTR up to position 0161 of the LTR (fragment A) and a
lished yet and is still rather presumptive. fragment extending from 0116 to 64 (fragment B) were
In the present study we confirmed that the stimulatory generated by PCR with the following primers: I, 5*-
effect of TPA on HIV-1 LTR was strictly dependent on ACCGCTCGAGAAGAGGCAGATGACAATGACCAT
PKC activation. By contrast, the stimulatory effect of TPA GAGCC-3* (for the 5*-end of fragment A); II, 5*-GAATTC-
on HTLV-I LTR was found not only to be independent of TCTGAGCTTATGATTTG-3* (for the 3*-end of fragment A);
PKC activation but rather antagonized by this activated III, 5*-AAGCTCAGAGAATTCCCATGTTTGTCAAGCCG-3*
enzyme. This PKC-independent effect was proved to re- (for the 5*-end of fragment B); IV, 5*-ACTCAACCGGCG-
quire the c-ets responsive region 1 (ERR1) located in the TGGAT-3* (for the 3*-end of fragment B). The nucleotides
U3 region, between positions0161 and0116 of this LTR marked by bold letters in primer III were extra-sequences
(Gitlin et al., 1991). added to the 5*-end of fragment B to complement the
sequences marked by bold letters in primer II, which
MATERIALS AND METHODS comprised the 3*-end of fragment A. The two fragments
were gel purified, combined in equal molar amounts, and
Cells
subjected to a second PCR with primers I and IV. During
this reaction the sense strand of fragment A and theJurkat cells were used throughout this study. The cells
antisense strand of fragment B annealed through theirwere grown in RPMI-1640 medium supplemented with
complementary 3*-ends and were converted by chain10% fetal calf serum.
elongation into a unified double-stranded fragment,
which was then amplified through the included primers.Plasmids
This amplified fragment, extending from the XhoI site up
Plasmids containing the complete LTRs (U3, R, U5) of to position 64, but lacking the entire ERR1, was digested
HIV-1 or HTLV-I, linked to the bacterial CAT reporter gene by XhoI and EcoNI (see Fig. 1B) and replaced the XhoI –
(designated HIV-1 LTR-CAT and HTLV-I LTR-CAT, re- EcoNI fragment of the original LTR. The structure of this
spectively), a plasmid containing the CAT gene without mutant was confirmed by restriction enzyme digestion
any promoter (designated dLTR-CAT) and a plasmid ex- and DNA sequencing.
pressing the HTLV-I tax gene via the CMV promoter (des-
DNA electroporation and CAT assayignated CMV-tax) were used. In addition, the method of
Loechelt et al. (1995) was adopted to construct a CAT The tested LTR-CAT plasmids (20 mg) were introduced
by electroporation into 107 viable cells (determined byreporter plasmid with an HTLV-I LTR mutant lacking the
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the trypan blue exclusion method), together with 20 mg
dLTR-CAT or with 10 mg CMV-tax and 10 mg dLTR-CAT.
CAT activity was assayed 48 hr later. Background activity
measured in control assays with extracts of cells electro-
porated with 40 mg dLTR-CAT plasmid alone were sub-
tracted from the experimental values and the net CAT
activity was normalized per milligram of extract protein.
Extract protein concentration was determined by the Bio-
Rad Protein Assay Reagent (see Revazova et al. (1995)
for further technical details).
Assay of Ca/2-dependent PKC activity
This activity was measured at various time-points of
the TPA (50 nM)-treatment, in the whole cell extract as
well as in the cytosolic and membranal subcellular frac-
tions, using slight modifications of the methods de-
scribed by Isakov and Altman (1987). Whole cell extracts
were prepared by lysing 3.5 1 107 cells in 3.5 ml of buffer
containing 20 mM Tris–HCl (pH 7.5), 2 mM EDTA, 5 mM
EGTA, 10 mM 2-mercaptoethanol, 50 mg/ml leupeptin, 50
mg/ml aprotonin, 2 mM phenylmethylsulfonyl fluoride,
and 1% Triton X-100. After 1 hr incubation in ice with
occasional mixing, the lysate was centrifuged at 100,000
g for 1 hr at 47 and the supernatant was saved. The FIG. 2. Translocation and downregulation of the Ca/2-dependent
subcellular fractions were prepared by suspending the PKC isoforms in TPA-treated Jurkat cells. Jurkat cells were incubated
with 50 nM TPA. (A) At the indicated times, total cell extract (h), ascells in the same buffer but without Triton X-100 and
well as the cytosolic (s) and membranal (n) subcellular fractions,lysing them by a brief sonication. These lysates were
prepared from these cells, were assayed for the activity of the Ca/2-centrifuged as above and the supernatants were used
dependent PKC isoforms. (B) The protein level of these enzymes was
as the cytosolic fractions. The pellets were resuspended determined in the indicated extracts prepared at 0 (lane 1), 1 (lane 2),
in the original volume of the same buffer with Triton X- and 72 hr (lane 3) of TPA treatment by Western blot analysis with a
polyclonal antiserum recognizing the a, b, and g PKC isoforms.100. After 1 hr incubation in ice, these suspensions were
centrifuged as above and the supernatants served as the
membranal fractions. PKC was enriched in all extracts by
analysis as described by Revazova et al. (1995), using a
a one-step elution from DE-52 ion exchange columns
rabbit antiserum recognizing the a, b, and g isoforms
with 0.1 M NaCl. Ca/2-dependent PKC activity was quan-
(kindly provided by N. Isakov, Ben Gurion University of
tified by measuring the phosphorylation of histone H1 in
the Negev, Israel. See Isakov et al., 1990) or mouse
50 ml reaction mixture containing 20 mM Tris–HCl (pH
monoclonal antibody detecting the e PKC isoforms (pur-
7.5), 20 mM MgCl2 , 10 mM [g-P
32]ATP (3000 Ci/mmol),
chased from Transduction Laboratories, Lexington KY),
280 mg/ml phosphatidylserine, 1 mM CaCl2 , 10 mg his- horseradish peroxidase-conjugated anti rabbit-Ig, or anti
tone H1, and 10 ml of the examined extract. After 5 min
mouse-Ig goat antibodies, respectively (Amersham Inter-
incubation at 307, the reaction was stopped by spotting
national plc, UK), and enhanced chemiluminescence de-
40 ml of each reaction mixture onto P-81 phosphocellu-
tection reagent (ECL, Amersham).
lose filter discs, which were then washed 4 times with 1%
phosphoric acid and twice with water and dried before
RESULTS
measuring their radioactivity. Parallel reactions were run
for each extract in the same mixture except that 1 mM TPA-induced PKC activation and downregulation in
EGTA replaced CaCl2 . Each reaction was performed in Jurkat cells
duplicates. The difference between the reaction values
We chose to address the question of whether activated
obtained with and without Ca/2 was regarded as repre-
PKC mediated the stimulatory effect of TPA on HTLV-I
senting the Ca/2-dependent PKC activity. This activity
LTR expression by examining this expression in Jurkat
was normalized per milligram extract protein.
cells depleted of PKC by long-term TPA pretreatment.
For this purpose, it was important to verify first that theseWestern blot analysis of PKC isoforms
cells could, indeed, be depleted of PKC by such treat-
ment. In the experiments presented in Fig. 2A, wholeThe whole cell as well as the cytosolic and membranal
extracts were analyzed for PKC isoforms by Western blot cell extracts as well as the cytosolic and membranal
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subfractions, prepared at the indicated time-points of the
TPA treatment, were analyzed for Ca/2-dependent PKC
activity. These experiments demonstrated an activation
of this enzyme, reflected by its translocation from the
cytosolic to the membranal fraction within the first hour
of treatment. This activation was followed by a gradual
decline of the enzyme activity in all the examined ex-
tracts, resulting in its almost complete depletion after 24
hr of treatment.
It is well established by now that PKC exists in several
isoforms, which are classified into three groups; the clas-
sical PKCs which are Ca/2-dependent and include the
a, b, and g isoforms, the new PKCs which are Ca/2-
independent and include the d, e, h, u, and m isoforms,
and the atypical z and l isoforms which are also Ca/2-
independent, but do not respond to TPA (Nishizuka,
1995). Thus, to further substantiate the results presented
in Fig. 2A, the extracts were examined for the presence
of the Ca/2-dependent PKCs by Western blot analysis
with an antiserum recognizing the a, b, and g isoforms
FIG. 3. Effect of long-term TPA pretreatment on CAT expression(Isakov et al., 1990). The results illustrated in Fig. 2B
directed by HIV-1 and HTLV-I LTRs. Jurkat cells were treated with 50
confirmed the translocation of these isoforms from the nM TPA for 72 hr and then transfected by electroporation with (A) HIV-
cytoplasm to the cell membrane within 1 hr of exposure 1 LTR-CAT or (B) HTLV-I LTR-CAT construct. TPA-untreated cells served
as a control. CAT activity was measured by the scintillation liquid diffu-to TPA and demonstrated their severe depletion from
sion method 24 hr after transfection and normalized for the proteinthe cells after long TPA treatment. A similar pattern was
concentration of each corresponding extract. This activity is presentedobserved by using a monoclonal antibody to detect the
here in relative terms compared to the control. The data represent the
e isoform as a representative of the Ca/2-independent average ({ standard deviation) of six repeated experiments.
PKCs (not shown). These data are consistent with the
finding of Tsutsumi et al. (1993). By detailed analysis of
Effect of TPA and PKC inhibitors on HIV-1 and HTLV-Iall PKC isoforms with specific monoclonal antibodies,
LTRsthese authors could not detect the g isoform in Jurkat
To further elucidate the above alternative possibilities,cells. However, they demonstrated in these cells a trans-
the cells were transfected first with the HIV-1 (Fig. 4A)location and subsequent downregulation of all the other
or HTLV-I (Fig. 4B) LTR-CAT constructs, and where indi-classical and new isoforms with slightly variable kinetics.
cated, the potent PKC inhibitors H7 (Hikada et al., 1984)
Effect of TPA induced PKC depletion on the and chelerythryn (Herbert et al., 1990) were added 1 hr
expression of HIV-1 and HTLV-I LTRs after transfection, whereas TPA was added 1 hr later.
These experiments demonstrated that TPA strongly stim-In the next set of experiments the cells were, first,
ulated the expression of HIV-1 LTR and that this stimula-depleted of PKC by a 72-hr TPA treatment and then elec-
tion was abolished by both PKC inhibitors. On the othertroporated with the HIV-1 LTR-CAT (Fig. 3A) or the HTLV-
hand, under these conditions, TPA alone stimulated theI LTR-CAT construct. The results of several repeated ex-
expression of HTLV-I LTR too, but this stimulation wasperiments demonstrated that this PKC depletion pro-
considerably lower than that induced by the long TPAfoundly reduced the basal expression of HIV-1 LTR-CAT.
pretreatment (compare Figs. 3B and 4B) and was remark-Strikingly, however, the expression of HTLV-I LTR-CAT
ably enhanced by both PKC inhibitors.was, by contrast, strongly stimulated in these PKC-de-
Taken together, the results presented in Figs. 3 andpleted cells. Such an opposite effect on these two con-
4 can be interpreted as indicating that while the basalstructs excluded the possible argument that these results
expression of HIV-1 LTR and its stimulation by TPA aremerely reflected an effect of the TPA pretreatment on the
both strictly dependent on PKC activity, this activity is notDNA uptake by the cells. These data suggest that even
only unneeded for the stimulatory effect of TPA on HTLV-the basal expression of the HIV-1 LTR requires some
I LTR, but seems even to antagonize it.basal level of PKC activity and it is diminished upon
depletion of this activity. On the other hand the stimula-
Effect of TPA on the expression of HTLV-Itory effect of TPA on HTLV-I LTR is probably induced by
LTR(dERR1) mutanta PKC-independent pathway, or is mediated by a long
lasting PKC-activated factor which remains active even Both HIV-1 and HTLV-I LTRs contain binding sites for
a variety of cellular transcription factors, some of whichlong after PKC depletion.
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fore, these data provide a further indication that the stim-
ulatory effect of TPA on HTLV-I LTR, whether added be-
fore or after transfection, was exerted by the same PKC-
independent mechanism and suggest that it is mediated
by a member of the ets family or other factors (Ge´gonne
et al., 1993; Marriott et al., 1990; Bosselut et al., 1992)
interacting with this region.
DISCUSSION
The present study was conducted to pursue the role
of PKC in the stimulatory effect of TPA on the expression
of HIV-1 and HTLV-I LTRs. While PKC depletion was
found to reduce the basal expression of the HIV-1 LTR,
it strongly stimulated the expression of HTLV-I LTR. Both
LTRs are regulated by a variety of cellular transcription
factors, some of which are common for both of them,
whereas others are unique. One of the factors that regu-
lates the HIV-I (Kawakami, 1988) but not the HTLV-I LTR
(Aboud et al., 1993) is NF-kB. This factor is sequestered
FIG. 4. Effect of posttransfection addition of TPA and PKC inhibitors in the cytoplasm by interaction with an IkB inhibitory
on CAT expression directed by HIV-1 and HTLV-I LTRs. Jurkat cells protein. Phosphorylation of this inhibitor by activated PKCwere first transfected by electroporation with (A) HIV-1 LTR-CAT or (B)
(and possibly by other kinases too) dissociates the NF-HTLV-I LTR-CAT construct. One hour later, the PKC inhibitors H7 (100
kB/IkB complex and leads to IkB degradation. This, inmM) or chelerythryn (CHE, 100 mM) were added to the indicated cul-
tures, whereas TPA (50 nM) was added to the indicated cultures after turn, allows NF-kB to translocate to the nucleus where
an additional 1 hr, to ensure the penetration of the inhibitors before it activates genes carrying NF-kB binding sites in their
TPA. Transfected cells with no subsequent additions served as control promoter–enhancer regions. Thus, activation of NF-kB(CONT). CAT activity was assayed and expressed as described in the
persists as long as the newly synthesized IkB moleculeslegend of Fig 2. The data represent the average ({ standard deviation)
keep being posphorylated and terminates when theof four repeated experiments.
phosphorylating kinase ceases to act (Ghosh and Balti-
more, 1990). It is likely that a basal level of active PKC,
present in the TPA-untreated cells, maintains a certainproved to regulate their expression. Some of these fac-
tors are commonly effective for both LTRs, whereas oth-
ers are unique to either of them. Therefore, to have a
clue for the mechanism of the PKC-independent effect
of TPA on HTLV-I LTR we decided to focus on the binding
sites of factors known to influence the expression of
HTLV-I but not of the HIV-1 LTR. The proto-oncogenes
c-ets-1 and c-ets-2 are examples for such factors (Bos-
selut et al., 1990). HTLV-I LTR has two c-ets responsive
regions ERR1 and ERR2 (Gitlin et al., 1991). The ERR1,
located between the two 21-bp tax responsive elements
(TRE) proximal to the transcription start point (see Fig. 1),
has been shown to be instrumental for tax-independent
stimulation of this LTR by both c-ets-1 and c-ets-2 (Gitlin
et al., 1991). Although a c-ets binding site exists within
the HIV-1 LTR too (Holzmeister et al., 1993), the c-ets
proteins have no effect on its expression (Bosselut et al.,
1990). Therefore we constructed the HTLV-I LTR(dERR1)
FIG. 5. Effect of TPA and tax on the expression of ERR1-deleted
mutant lacking the entire ERR1 (see Fig. 1). The results HTLV-I LTR mutant. The mutant HTLV-I LTR(dERR1)-CAT construct was
shown in Fig. 5 demonstrate that this mutant totally lost electroporated to untreated cells (column A) or to cells pretreated with
TPA for 72 (column B). In parallel the construct was introduced firstits responsiveness to TPA, regardless of whether TPA
into the cells and TPA was added I hr later (column C). As a positivewas added 72 hr before or 1 hr after transfection. This
control for the biological activity of this construct it was cotransfected
mutant was highly responsive to cotransfected tax-ex- with an HTLV-I tax (CMV-tax) expressing vector into untreated cells
pressing vector (Fig. 5), indicating that the mutation did (column D). The data represent the average ({ standard deviation) of
3 repeated experiments.not disrupt other biological activities of the LTR. There-
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level of active NF-kB, which is responsible for the basal iments, are not strictly specific to PKC and can inhibit,
although to a lesser extent, other protein kinases tooHIV-1 LTR expression. Therefore, the reduced HIV-1 LTR
expression observed in the PKC-depleted cells might re- (Nishizuka, 1995). Therefore, it could be argued that while
the effect of TPA on the HTLV-I LTR was indeed PKC-flect a diminution of the basal active NF-kB due to this
PKC depletion. In contrast, the stimulatory effect of TPA independent, this effect might be antagonized by other
kinases rather than by PKC. However, such an argumenton the HTLV-I LTR could be attributed to a long lasting
factor that, in these experiments, was induced by the is inconsistent with our finding that the stimulatory effect
of the long TPA pretreatment on this LTR was muchTPA-activated PKC before its depletion from the cells. An
example for such a long lasting factor is the c-jun protein, higher than that induced by TPA added after transfection,
because TPA is not known to downregulate protein ki-whose induction persists from few hours up to several
days, depending on the cell type and the inducing stimu- nases other than PKC.
Of interest in this context are several earlier reportslus (Karin, 1990). The DNA binding activity of this protein
is stimulated by a PKC-activated nuclear protein-phos- demonstrating that some of the TPA biological effects
are not necessarily PKC-dependent (Kraft et al., 1986;phatase that dephosphorylates one or more inhibitory
phosphorylated sites near its DNA binding domain (Boyle Motasim-Bllah et al., 1989; Murphy et al., 1991). A well-
documented example for a non-PKC signaling elementet al., 1991). In addition to inducing the expression of
several other genes, this activated factor upregulates its that is activated by the mere binding of TPA is the
protein encoded by the Vav proto-oncogene, whichown encoding gene (Angel et al., 1988). While c-jun by
itself alone is capable of activating the HTLV-I LTR (Ab- participates in ras-associated signal transduction
pathways in lymphoid cells (Gulbins et al., 1994). Nota-oud et al., 1993), this factor affects the HIV-1 LTR only as
a component of the c-jun/c-fos AP-1 heterodimer (Luciw, bly, among the genes that are modulated by ras-asso-
ciated signals are the c-jun (Binetury et al., 1991) and1996). This heterodimer is a short lasting factor because
of the quick but transient induction of c-fos (Karin, 1990). the c-ets-1 and c-ets-2 (Yang et al., 1996) proto-onco-
genes. These are transcription factors which can acti-Another possible interpretation for these data could
emerge from numerous studies focusing on the mecha- vate the LTR of HTLV-I but not of HIV-1 (Aboud et al.,
1993; Bosselut et al., 1990; Luciw, 1996). Our experi-nisms of short versus long lasting biological effects of
TPA and other stimuli of PKC-associated pathways (Nish- ments with the HTLV-I LTR(dERR1) mutant strongly
point to the involvement of c-ets family members inzuka, 1995). It has been shown that while most of the
PKC molecules that translocate to the cell membrane are mediating this PKC-independent effect of TPA, al-
though we still cannot exclude the possibility that theycleaved by a membrane bound Ca/2-dependent prote-
ase, a small fraction of these molecules remains inserted act in conjunction with some other factors. Further-
more, ERR1 contains also binding sites for other fac-in a permanently active Ca/2-independent form within
the membrane lipid bilayer. The substrate specificity of tors like Sp1 (Ge´gonne et al., 1993), TIF-1 (Marriott et
al., 1990), and myb (Bosselut et al., 1992), which shouldthe PKC molecules, which leads to the particular biologi-
cal effect evoked by a given stimulus in a given cell type, be considered as additional possible candidates medi-
ating this effect.is believed to be determined by the specific combination
of the PKC-activating membranal lipid metabolites
formed in the examined cells in response to this stimulus. ACKNOWLEDGMENTS
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